Volume: 38 Issue: 4
CIM-Sanjeevani: A high artemisinin yielding population of Artemisia (Artemisia annua)
Year: 2016, Page: 78-83, Doi: https://doi.org/10.62029/jmaps.v38i4.Gupta
Received: Aug. 1, 2016 Accepted: Sept. 1, 2016 Published: Dec. 31, 2016
Artemisia annua L. (Asteraceae), commonly known as quinghao, is a traditional medicinal herb, native to China and widely grown in Asia and Europe. The biologically active compound artemisinin isolated from the herb of the A. annua is used as an anti-malarial drug. CSIR-CIMAP has now developed genetically improved variety of Artemisia annua with artemisinin content of 1.2%. The new variety CIM-Sanjeevani has been developed using classical breeding method of poly crossing between two existing varieties i.e. Jeevan Raksha and CIM-Arogya followed by population enrichment with desirable genes. Two way selections were practiced, which involves selection for maternal parent and simultaneous rejection of poor pollinators from the population. The plants of variety CIM-Sanjeevani has a yield potential of producing average 50-55 kg of artemisinin from an average dry herb yield of 43 – 45 q/ha in a single harvest. The plants of the variety CIM-Sanjeevani have intermediate morphology between variety Jeevan Raksha and CIM-Arogya. This variety is about 10 days late in flowering as compared to two earlier varieties and therefore also suited for three harvests. This variety will benefit both farmers and industries involved in Artemisia cultivation / business. Industry may have the benefit of reduced cost of production by a margin of 20%.
Keywords: CIM-Arogya, Jeevan Raksha, Malaria, Poly-cross, Population improvement.
Anonymous. 2015. The CNAP Artemisia Research Project, CNAP, Department of Biology (Area 7), The University of York, Heslington, York, UK.
Khan MMAA, Jain DC, Bhakuni RS, Zaim M, Thakur RS. 1991. Occurrence of some antiviral sterols in Artemisia annua. Pl Sci 75: 161–165.
Li S, Chen C, Zhang H, Guo H, Wang H, Wang L, Zhang X, Hua S, Yu J, Xiao P, Li R, Tan X. 2005. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res 67: 18–23.
Mishina YV, Krishna S, Haynes RK, Meade JC.2007. Artemisinins Inhibit Trypanosoma cruzi and Trypanosoma brucei rhodesiense In Vitro Growth. Antimicrob Agents Chemother 51: 1852–1854.
Sen R, Bandyopadhyay S, Dutta A, Mandal G, Ganguly S, Saha P, Chatterjee M. 2007. Artemisinin triggers induction of cell-cycle arrest and apoptosis in Leishmania donovani promastigotes. J Med Microbiol 56: 1213–1218.
Singh RK, Chaudhary BD. 1979. Biometrical methods in quantitative genetic analysis. New Delhi, Kalyani publication, P 120.
WHO Position Statement, June 2012. Effectiveness of Non-Pharmaceutical Forms of Artemisia annua L. against malaria.
Yang DM, Liew FY. 1993. Effects of qinghaosu (artemisinin) and its derivatives on experimental cutaneous leishmaniasis. Parasitol 106: 7–11.
© Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow (India)
Anil Kumar Gupta, Madan Mohan Gupta, Abhilasha Srivastava, Ravi Prakash Bansal, Raj Kishori Lal, Ajit Kumar Shasany, Dharmendra Saikia, OM Prakash Dhawan, Sudeep Tandon, Ritu Mishra, Priyanka Maurya, Mohammad Zaim, Alok Kalra, Ashok Kumar Srivastava, Tripta Jhang, Ram Ujagir, Rajesh Verma, Karuna Shanker, Sanjay Kumar, Sushil Kumar. 2016. CIM-Sanjeevani: A high artemisinin yielding population of Artemisia (Artemisia annua). J Med Aromat Plant Sci 38: 78-83.
